Immunitybio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $7,552 | $6,106 | $1,047 | $40 |
Gross Profit | 7,552 | 6,106 | 1,047 | -4,515 |
EBITDA | -40,120 | -41,066 | -91,159 | -92,088 |
EBIT | -44,274 | -45,505 | -95,565 | -96,643 |
Net Income | -59,162 | -85,729 | -134,564 | -134,109 |
Net Change In Cash | 7,552 | 6,106 | 1,047 | 40 |
Free Cash Flow | -85,144 | -101,555 | -101,071 | -108,243 |
Cash | 143,428 | 111,966 | 130,104 | 133,035 |
Basic Shares | 734,542 | 697,961 | 686,938 | 672,831 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $14,745 | $622 | $240 | $934 |
Gross Profit | 14,745 | 622 | -23,952 | 934 |
EBITDA | -264,433 | -436,182 | -335,511 | -315,380 |
EBIT | -281,987 | -454,694 | -359,703 | -334,502 |
Net Income | -413,564 | -583,196 | -417,320 | -349,848 |
Net Change In Cash | 14,745 | 622 | 240 | 934 |
Cost of Revenue | -76,599 | 146,138 | ||
Free Cash Flow | -398,124 | -397,341 | -436,900 | -307,982 |
Cash | 143,428 | 265,453 | 104,641 | 181,101 |
Basic Shares | 700,443 | 508,635 | 399,900 | 389,234 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.08 |
2024-09-30 | -$0.12 |
2024-06-30 | -$0.20 |
2024-03-31 | -$0.20 |
